Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Putting the theory of personalised medicine into practice

Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert Leonard
Putting the theory of personalised medicine into practice ( Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert Leonard )
8 Oct 2012

Treatment of ALK+ lung cancer with crizotinib, Profile 1007

Dr Alice Shaw – Massachusetts General Hospital, Boston, USA
Treatment of ALK+ lung cancer with crizotinib, Profile 1007 ( Dr Alice Shaw – Massachusetts General Hospital, Boston, USA )
8 Oct 2012

The first phase II trial for the management of oesophageal cancer

Prof David Ferry – New Cross Hospital, Wolverhampton, UK
The first phase II trial for the management of oesophageal cancer ( Prof David Ferry – New Cross Hospital, Wolverhampton, UK )
8 Oct 2012

Phase III MISSION trial: Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer

Dr Tony Mok – The Chinese University of Hong Kong
Phase III MISSION trial: Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer ( Dr Tony Mok – The Chinese University of Hong Kong )
8 Oct 2012

Trametinib and dabrafenib combination therapy against metastatic melanoma

Dr Georgina Long – Westmead Hospital, The University of Sydney, Australia
Trametinib and dabrafenib combination therapy against metastatic melanoma ( Dr Georgina Long – Westmead Hospital, The University of Sydney, Australia )
8 Oct 2012

New developments in molecular imaging

Prof Wim Oyen – Radboud University Nijmagen Medical Centre, Netherlands
New developments in molecular imaging ( Prof Wim Oyen – Radboud University Nijmagen Medical Centre, Netherlands )
5 Oct 2012

Personalised cancer medicine and research: Today’s best practice

Prof José Baselga - Massachusetts General Hospital, Boston, USA
Personalised cancer medicine and research: Today’s best practice ( Prof José Baselga - Massachusetts General Hospital, Boston, USA )
5 Oct 2012

Treating liver metastases in colorectal cancer

Dr Gunnar Folprecht - University Cancer Center, Dresden, Germany
Treating liver metastases in colorectal cancer ( Dr Gunnar Folprecht - University Cancer Center, Dresden, Germany )
4 Oct 2012

Putting drugs to work against brain metastases in HER2 positive breast cancer: LANDSCAPE study

Dr Thomas Bachelot – Centre Leon Berard, Lyon
Putting drugs to work against brain metastases in HER2 positive breast cancer: LANDSCAPE study ( Dr Thomas Bachelot – Centre Leon Berard, Lyon )
4 Oct 2012

The Multinational Association of Supportive Care in Cancer (MASCC)

Dr Stephen Grunberg – University of Vermont, Burlington, USA
The Multinational Association of Supportive Care in Cancer (MASCC) ( Dr Stephen Grunberg – University of Vermont, Burlington, USA )
4 Oct 2012

Defining personalised medicine and patient empowerment

Prof Gabriella Pravettoni – University of Milan, Italy
Defining personalised medicine and patient empowerment ( Prof Gabriella Pravettoni – University of Milan, Italy )
4 Oct 2012

Phase I study examining PI 3 kinase inhibitor for various tumours

Dr Pamela Munster – University of California, San Francisco, USA
Phase I study examining PI 3 kinase inhibitor for various tumours ( Dr Pamela Munster – University of California, San Francisco, USA )
4 Oct 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation